Published in Clin Endosc on November 30, 2014
Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical Considerations. Gut Liver (2016) 0.91
Emerging blood-based biomarkers for detection of gastric cancer. World J Gastroenterol (2015) 0.86
Long-term survival trends of gastric cancer patients between 1972 and 2011 in Qidong. Chin J Cancer (2015) 0.84
Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. BMC Cancer (2016) 0.82
Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer. Oncotarget (2016) 0.81
Review on the Applications and Molecular Mechanisms of Xihuang Pill in Tumor Treatment. Evid Based Complement Alternat Med (2015) 0.81
Recent developments and innovations in gastric cancer. World J Gastroenterol (2016) 0.81
Helicobacter pylori in gastric carcinogenesis. World J Gastrointest Oncol (2015) 0.80
Peripheral trafficking of bone-marrow-derived stem cells in patients with different types of gastric neoplasms. Oncoimmunology (2015) 0.79
Relationship between socioeconomic status and accessibility for endoscopic resection among gastric cancer patients: using National Health Insurance Cohort in Korea: poverty and endoscopic resection. Gastric Cancer (2016) 0.78
A Novel Prognostic Score, Based on Preoperative Nutritional Status, Predicts Outcomes of Patients after Curative Resection for Gastric Cancer. J Cancer (2016) 0.78
xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases. Front Microbiol (2015) 0.77
Etiology and Prevention of Gastric Cancer. Gastrointest Tumors (2016) 0.77
Evaluation of selected interleukins in patients with different gastric neoplasms: a preliminary report. Sci Rep (2015) 0.76
Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland. Med Sci Monit (2016) 0.75
DO PROXIMAL AND DISTAL GASTRIC TUMOURS BEHAVE DIFFERENTLY? Arq Bras Cir Dig (2017) 0.75
Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer. Oncotarget (2017) 0.75
Helicobacter pylori gene silencing in vivo demonstrates urease is essential for chronic infection. PLoS Pathog (2017) 0.75
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Helicobacter pylori infection. N Engl J Med (2002) 14.81
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc (2003) 8.43
A human model of gastric carcinogenesis. Cancer Res (1988) 6.52
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat (2014) 5.97
Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol (2008) 4.44
Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science (2003) 3.00
Gastrointestinal epithelial neoplasia: Vienna revisited. Gut (2002) 2.98
Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer (2004) 2.88
The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol (2008) 2.56
Helicobacter infection and gastric neoplasia. J Pathol (2006) 2.54
Early gastric cancer in Europe. Gut (1997) 2.34
Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. IARC Monogr Eval Carcinog Risks Hum (1997) 2.28
Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol (2003) 2.23
Seroprevalence of Helicobacter pylori in South Korea. Helicobacter (2007) 2.21
Interleukin-1B polymorphisms and gastric cancer risk--a meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 1.90
Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst (2012) 1.88
Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol (2013) 1.83
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer (2006) 1.71
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol (2004) 1.59
High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res (1999) 1.55
Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer (2004) 1.54
Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol (2012) 1.53
Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol (2009) 1.51
Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer (2014) 1.50
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc (2010) 1.46
Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis (2006) 1.43
Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res (2007) 1.38
No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med (2002) 1.33
Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol (2006) 1.32
Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol (2002) 1.31
Screening for gastric cancer in Japan. Gastric Cancer (2000) 1.31
Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci (2010) 1.29
Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci U S A (2011) 1.27
Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One (2012) 1.26
The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol (2010) 1.25
The time to eradicate gastric cancer is now. Gut (2005) 1.22
A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One (2013) 1.20
Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology (2009) 1.18
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br J Cancer (2011) 1.18
High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int J Cancer (2006) 1.18
High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infect Immun (2013) 1.16
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701). Cancer Causes Control (2012) 1.15
The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut (1998) 1.13
Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia. Int J Cancer (1999) 1.13
The current state of diagnosis and treatment for early gastric cancer. Diagn Ther Endosc (2013) 1.10
Significant prognostic factors in patients with early gastric cancer. Int Surg (2001) 1.09
Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea. Cancer Sci (2011) 1.09
Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol (2007) 1.06
Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med (2011) 1.05
Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients. World J Gastroenterol (2005) 1.04
Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer. J Clin Pathol (2007) 1.04
N-Nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Am J Clin Nutr (2011) 1.02
Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes. Helicobacter (2004) 1.01
Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea. World J Gastroenterol (2010) 0.99
Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community. Int J Cancer (2011) 0.99
Evaluation of gastric biopsies for neoplasia: differences between Japanese and Western pathologists. Am J Surg Pathol (1999) 0.98
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol (2011) 0.97
Prevention of gastric cancer. JAMA (2014) 0.96
Cause and effect between concentration-dependent tissue damage and temporary cell proliferation in rat stomach mucosa by NaCl, a stomach tumor promoter. Carcinogenesis (1996) 0.95
Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma. J Surg Oncol (2012) 0.93
Evaluation of the aetiological role of dietary salt exposure in gastric and other cancers in humans. Food Chem Toxicol (1997) 0.93
Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter (2013) 0.91
Synergistic upregulation of inducible nitric oxide synthase and cyclooxygenase-2 in gastric mucosa of Mongolian gerbils by a high-salt diet and Helicobacter pylori infection. Histol Histopathol (2008) 0.88
Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. Int J Cancer (2014) 0.87
A novel germline mutation of the LKB1 gene in a patient with Peutz-Jeghers syndrome with early-onset gastric cancer. J Gastroenterol (2004) 0.85
Reduction of gastric cancer mortality by endoscopic and radiographic screening in an isolated island: A retrospective cohort study. Aust J Rural Health (2013) 0.84
Characteristics of gastric cancer invading to the proper muscle layer--with special reference to mortality and cause of death. Jpn J Clin Oncol (1985) 0.83
Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia. Eur J Gastroenterol Hepatol (2012) 0.81
Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed? Curr Oncol Rep (2013) 0.81
Relationship of Helicobacter pylori CagA(+) status to gastric juice vitamin C levels. Eur J Clin Invest (1999) 0.81
Value of gastrin-17 in detecting antral atrophy. Adv Med Sci (2011) 0.80
Gastrointestinal cancers in a peutz-jeghers syndrome family: a case report. Clin Endosc (2013) 0.79